|
|
|
|
|
24.03.26 - 21:48
|
XFRA: Deletion of Instruments from Boerse Frankfurt - 24.03.2026 (XETRA)
|
|
|
The following instruments on Boerse Frankfurt do have their last trading day on 24.03.2026.
Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.03.2026.
ISIN Name
CA4013392051 GUARDIAN CAPITAL GRP
CA4013393042 GUARDIAN CAP. GRP A
FR0010907956 CARMAT EO -,04
LU0934195610 ROB.GL.T.R.BD F.DH EO
NO0013671115 INTL PETROL 25/30
US30063P1057 EXACT SCIEN. DL-,01
US5834352016 STEAKHOLDER F.NEW ADR/100
US68237Q2030 ONCONETIX INC.
US98386D3070 XTL BIOPHARMA. ADR 100
XS3307259237 IBERDROLA FINANZAS S.A....
|
|
|
23.03.26 - 13:54
|
Abbott completes acquisition of Exact Sciences (PR Newswire)
|
|
|
Establishes Abbott as a leader in fast-growing cancer screening and diagnostics segments Advances Abbott's mission to make healthcare more accessible and give people more control over their health ABBOTT PARK, Ill., March 23, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has......
|
|
|
|
|
23.03.26 - 08:27
|
XFRA: EXK: Aussetzung/Suspension (XETRA)
|
|
|
DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
EXACT SCIEN. DL-,01 EXK US30063P1057 BAW/UFN...
|
|
|
|
|
|
|
|
|
03.03.26 - 16:03
|
KeyCare Raises $27.4 Million to Scale their AI-Powered, Epic-Based Virtual Care Solution for Health Systems (Business Wire)
|
|
|
Led by HealthX Ventures, the round will accelerate development of KeyCare's AI-enabled virtual care as demand for access to high-quality, coordinated virtual care continues to surgeCHICAGO--(BUSINESS WIRE)--KeyCare, the nation's first Epic-based virtual care company, today announced the close of a $27.4M financing round. The most recent round was led by HealthX Ventures and included participation from 8VC, LRVHealth, BOLD Capital Partners, and Ikigai Venture Partners. Additionally, this financing included a variety of strategic partners, such as WellSpan Health, Allina Health, University of Chicago Ventures, Edge Ventures (investment arm of Emplify Health), and Exact Sciences, Inc. This latest funding round brings KeyCare's total capital raised to over $55 million.
KeyCare's virtual care medical group, working on their optimized instance of Epic, has become a trusted primary care extension partner for health systems - allowing for easy patient access that improves access and quality of care. Through a...
|
|
|
|
|
|
|
|
|
20.02.26 - 22:09
|
Exact Sciences Stockholders Approve Acquisition by Abbott (Business Wire)
|
|
|
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (NYSE: ABT) at the special meeting of stockholders held earlier today.
At the special meeting, preliminary results showed that more than 99% of the votes cast, representing approximately 67% of the total outstanding shares of Exact Sciences common stock as of the January 9, 2026 record date for the special meeting, were voted in favor of the transaction. Final voting results from the special meeting will be reported by Exact Sciences in a Current Report on Form 8‑K filed with the U.S. Securities and Exchange Commission (the “SEC”).
Subject to the satisfaction or waiver of the remaining conditions to closing, the transaction is expected to close before the end of the second calendar quarter of 2026. Under the terms of the definitive agree...
|
|
|
|
|
|
|
13.02.26 - 23:54
|
Exact Sciences Q4 Loss Narrows As Revenues Gain (AFX)
|
|
|
WASHINGTON (dpa-AFX) - Exact Sciences Corporation (EXAS) on Friday, reported higher revenue for both the fourth quarter and full year ended December 31, 2025, while significantly narrowing its los......
|
|
|
13.02.26 - 22:09
|
Exact Sciences Announces Record Fourth Quarter and Full Year 2025 Results (Business Wire)
|
|
|
Fourth quarter and 2025 highlights
Total fourth quarter revenue of $878 million, an increase of 23% on a reported and core revenue basis, with Screening revenue of $695 million and Precision Oncology revenue of $183 million
Total 2025 revenue of $3.25 billion, an increase of 18% on a reported and core revenue basis, with Screening revenue of $2.53 billion and Precision Oncology revenue of $717 million
Operating cash flow was $491 million and free cash flow was $357 million for the full-year 2025, an improvement of 133% and 379%, respectively
Net loss was $208 million and adjusted EBITDA was $400 million for the full-year 2025, an improvement of $821 million and $77 million, respectively
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the Company generated revenue of $878 million for the fourth quarter of 2025 and $3.25 billion for the full year of 2025, both ended December 31, 2025.
“In 2025 the Exact ...
|
|
|
|
|
|
|
20.01.26 - 14:00
|
Here Are Tuesday′s Top Wall Street Analyst Research Calls: Chevron, Domino’s Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More (24/7 Wall St.)
|
|
|
Pre-Market Stock Futures: Futures are trading dramatically lower as we start the holiday-shortened trading week, following yesterday's MLK remembrance day. The futures downdraft this morning is being attributed to President Trump's threat to raise tariffs significantly over Greenland. Last Friday, the market closed unchanged primarily after a sizable options expiration that boosted trading volume throughout ... Here Are Tuesday's Top Wall Street Analyst Research Calls: Chevron, Domino's Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More
The post Here Are Tuesday's Top Wall Street Analyst Research Calls: Chevron, Domino's Pizza, Doximity, Exact Sciences, Intel, NetApp, StubHub, Toast, and More appeared first on 24/7 Wall St.....
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
